View Profile

Francesco Grussu

Senior Investigator, Radiomics Group · Vall d'Hebron Institute of Oncology

https://researchid.co/fgrussu
@vhio.net
70Scopus Publications
2711Google Scholar Citations
26Google Scholar h-index
45Google Scholar i10-index

Biography

I graduated from the University of Cagliari (BEng Biomedical engineering, 2009) and University of Genoa (MEng Bioengineering, 2012), Italy. I then obtained a PhD from University College London (UCL, UK) in Magnetic Resonance Physics (2016). I worked as a post-doc at UCL from 2016 to 2020, where I investigated new ways of acquiring and analysing spinal cord diffusion MRI scans in multiple sclerosis. During my post-doc, I visited New York University (NY, USA) in 2017 (Sept-Nov), and I was elected Trainee representative (2018-2020) of the International Society for Magnetic Resonance in Medicine (ISMRM) White Matter Study Group. From October 2020 I have been a post-doctoral researcher at the Vall d’Hebron Institute of Oncology, where I work on MRI for precision medicine in oncology. In September 2021 he was awarded a Beatriu de Pinós Fellowship, and from September 2022 I am a “la Caixa” Foundation Junior Leader Fellow. From January 1st 2025, I am Senior Investigator at VHIO.

Education

- BEng Biomedical Engineering, University of Cagliari, Italy (2006) - MEng Bioengineering, University of Genova, Italy (2012) - PhD MRI Physics, University College London (UCL), UK (2016)

Recent Scopus Publications

  1. Simulation-Informed Evaluation of Microvascular Parameter Mapping for Diffusion MR Imaging of Solid Tumours
    Magnetic Resonance in Medicine, 2026
  2. The Sense of Smell (SoS) Atlas: Its Creation and First Application to Investigate COVID-19 Related Anosmia With a Comprehensive Quantitative MRI Protocol
    Journal of Magnetic Resonance Imaging, 2026
  3. Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy
    Clinical Cancer Research, 2026
  4. ESR Essentials: diffusion-weighted MRI—practice recommendations by the European Society for Magnetic Resonance in Medicine and Biology
    European Radiology, 2026
  5. Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI: Part 2—Ex vivo imaging: Added value and acquisition
    Magnetic Resonance in Medicine, 2025

Links